U.S Physical Therapy Total Liabilities 2012-2026 | USPH

U.S Physical Therapy total liabilities from 2012 to 2026. Total liabilities can be defined as the total value of all possible claims against the corporation.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
U.S Physical Therapy Annual Total Liabilities
(Millions of US $)
2024 $677
2023 $520
2022 $541
2021 $452
2020 $317
2019 $319
2018 $226
2017 $213
2016 $163
2015 $131
2014 $77
2013 $73
2012 $37
2011 $42
U.S Physical Therapy Quarterly Total Liabilities
(Millions of US $)
2025-09-30 $691
2025-06-30 $677
2025-03-31 $681
2024-12-31 $677
2024-09-30 $545
2024-06-30 $538
2024-03-31 $536
2023-12-31 $520
2023-09-30 $517
2023-06-30 $510
2023-03-31 $549
2022-12-31 $541
2022-09-30 $481
2022-06-30 $488
2022-03-31 $462
2021-12-31 $452
2021-09-30 $339
2021-06-30 $338
2021-03-31 $321
2020-12-31 $317
2020-09-30 $310
2020-06-30 $328
2020-03-31 $401
2019-12-31 $319
2019-09-30 $328
2019-06-30 $326
2019-03-31 $302
2018-12-31 $226
2018-09-30 $242
2018-06-30 $228
2018-03-31 $209
2017-12-31 $213
2017-09-30 $211
2017-06-30 $221
2017-03-31 $195
2016-12-31 $163
2016-09-30 $91
2016-06-30 $99
2016-03-31 $102
2015-12-31 $131
2015-09-30 $90
2015-06-30 $86
2015-03-31 $81
2014-12-31 $77
2014-09-30 $85
2014-06-30 $76
2014-03-31 $74
2013-12-31 $73
2013-09-30 $33
2013-06-30 $35
2013-03-31 $37
2012-12-31 $37
2012-09-30 $34
2012-06-30 $38
2012-03-31 $39
2011-12-31 $42
2011-09-30 $42
2011-06-30 $32
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.157B $0.781B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.514B 13.37
Quest Diagnostics (DGX) United States $21.197B 19.44
Elanco Animal Health (ELAN) United States $11.500B 24.35
Encompass Health (EHC) United States $10.662B 19.64
DaVita (DVA) United States $10.023B 13.82
Chemed (CHE) United States $5.639B 19.57
Option Care Health (OPCH) United States $4.553B 18.71
RadNet (RDNT) United States $4.302B 142.13
LifeStance Health (LFST) United States $2.495B 320.00
Addus HomeCare (ADUS) United States $1.719B 16.61
Astrana Health (ASTH) United States $1.536B 31.40
Aveanna Healthcare Holdings (AVAH) United States $1.353B 12.20
Pennant (PNTG) United States $1.072B 31.31
Daxor (DXR) United States $0.048B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.032B 0.00
Psychemedics (PMD) United States $0.000B 0.00